首页 | 本学科首页   官方微博 | 高级检索  
     

支气管肺发育不良管理中糖皮质激素选择的循证依据与个体化
引用本文:李娟. 支气管肺发育不良管理中糖皮质激素选择的循证依据与个体化[J]. 中国小儿急救医学, 2016, 0(12): 815-819. DOI: 10.3760/cma.j.issn.1673-4912.2016.12.004
作者姓名:李娟
作者单位:中国医科大学附属盛京医院儿科, 沈阳,110004
摘    要:
尽管超早产儿存活率明显提高,支气管肺发育不良( bronchopulmonary dysplasia,BPD)始终是早产儿主要疾病及影响至成年呼吸和神经健康的最常见并发症,可持续至成年并影响呼吸及神经系统发育。糖皮质激素明显有益于BPD,但用于BPD的防治中还有许多争议,应参考已有的研究结果并结合新生儿临床特点谨慎应用。

关 键 词:早产儿  支气管肺发育不良  糖皮质激素

Evidence-based and individual corticosteroids therapies for bronchopulmonary dysplasia
Abstract:
Despite survival of extremely preterm infants has increased over recent years,bronchopul-monary dysplasia( BPD) remains both a major cause of mortality and one of the most common complications with implications into adulthood on respiratory and neurologic health. Steroids have a clear beneficial effect on BPD,but there is much debate surrounding the use of corticosteroids on the prevention and treatment of BPD. Careful consideration of the available data along with the clinical characteristics of the individual infant is required before being introduced into therapy.
Keywords:Preterm infant  Bronchopulmonary dysplasia  Corticosteroids
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号